冠状病毒肺炎治疗进展

Progress in the treatment of coronavirus pneumonia

冠状病毒肺炎是由冠状病毒感染引起的肺炎。2003年的严重急性呼吸综合征(SARS)、2012年的中东呼吸综合征(MERS)和2019年的新型冠状病毒肺炎(COVID-19)皆由冠状病毒引发。这些疾病的流行给世界人民造成了深重的灾难。然而,至今还没有治疗冠状病毒肺炎的特效药。鉴于当前世界范围内COVID-19疫情的态势,开发有效的抗病毒药物显得尤为紧迫。本文综述了新型冠状病毒肺炎治疗药物的相关进展,希望为疫情的防控提供帮助。

Coronavirus pneumonia is caused by coronavirus infection.Severe acute respiratory syndrome(SARS)in 2003,Middle east respiratory syndrome(MERS)in 2012,and coronavirus disease 2019(COVID-19)in 2019 were all caused by coronavirus.The prevalence of these diseases has caused great disaster to people all over the world.However,there is no specific drug for the treatment of coronavirus pneumonia.In view of the current worldwide epidemic situation of covid-19,it is particularly urgent to develop effective antiviral drugs.This article reviews the progress in the treatment of new coronavirus pneumonia,hoping to provide help for the prevention and control of the disease.